CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 4/A Other acquisition Director acquired 3,073,298 shares (other)
- 15-12G Other 15-12G
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 4 Other acquisition 10% owner acquired 53,578,209 shares (other)
- 4 Other acquisition Director acquired 17,497,336 shares (other)
- 4 Other acquisition Member of 13D Group acquired 26,905,073 shares (other)
- 4 Other acquisition President & Co-CEO acquired 21,269,420 shares (other)
- 4 Other acquisition Co-CEO acquired 24,753,252 shares (other)
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
Page 13 of 35 · 695 filings